GOPIKA N ARE

Allopathic & Osteopathic Physicians|Obstetrics & Gynecology BROOKLYN, NY NPI 1629159702

General Payments — all program years on this page

$3,134.52

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 153
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $489.04 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $489.0421

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $296.8016
2019 $307.6616
2020 $121.697
2021 $302.2414
2022 $704.5435
2023 $912.5544
2024 $489.0421

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1089394266 Daiichi Sankyo Inc. $28.49 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104805951 Biogen, Inc. $29.76 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104852610 Biogen, Inc. $28.13 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131596690 PFIZER INC. $21.29 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136304941 Organon Llc $13.29 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139269032 Astellas Pharma US Inc $29.27 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139280172 Astellas Pharma US Inc $23.21 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139331072 Astellas Pharma US Inc $24.10 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139341714 Astellas Pharma US Inc $19.71 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139417383 Astellas Pharma US Inc $22.99 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141861212 Merck Sharp & Dohme LLC $24.87 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148822114 Sumitomo Pharma America, Inc. $23.49 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148822116 Sumitomo Pharma America, Inc. $22.10 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149985016 Exeltis, USA Inc. $19.23 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150132759 SHIELD THERAPEUTICS INC $24.07 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150799299 CooperSurgical, Inc. $22.45 06/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150799335 CooperSurgical, Inc. $23.29 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154697683 MAYNE PHARMA COMMERCIAL LLC $29.59 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154841416 Agile Therapeutics, Inc. $17.94 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154842799 Agile Therapeutics, Inc. $23.84 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154843309 Agile Therapeutics, Inc. $17.93 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.